Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety
Our study demonstrates that omadacycline treatment can achieve favorable clinical success and bacterial clearance, with positive safety and tolerability outcomes. However, high-quality randomized controlled trials are needed to validate these initial findings.
Authors
- Wenchao Gao (ORCID: https://orcid.org/0000-0002-1382-6210)
- Yan He (ORCID: https://orcid.org/0000-0003-2836-1767)
- Shuyun Xu (ORCID: https://orcid.org/0000-0002-2647-754X)
- Dong Liu (ORCID: https://orcid.org/0000-0002-2928-3548)
- Xueqing Zhang (ORCID: https://orcid.org/0000-0003-1315-5709)
- Lei Tian (ORCID: https://orcid.org/0000-0002-7485-9366)
- Dong Xu (ORCID: https://orcid.org/0000-0002-7772-9479)
- Jian Yang (ORCID: https://orcid.org/0000-0003-4255-9622)
Institutions
- Central People's Hospital of Zhanjiang (CN)
- People's Liberation Army 401 Hospital (CN)
- Tongji Hospital (CN)
- Chinese People's Liberation Army (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1007/s40121-024-01065-3
- Citations
- 6
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 1.02
Funders
- Guangdong Medical Research Foundation